30 Aug
Top 5 Oncology Drugs in the Global Pharmaceutical Industry (2017)
Oncology drugs is one of the fastest-growing segments in the global pharmaceutical industry. Over the next five years, oncology drug sales are expected to exceed USD 90 billion—a staggering number
25 Aug
Novartis Expands Cancer Drugs Portfolio as Kisqali Receives EU Approval
The newest of Novartis’s cancer drugs, Kisqali, has received European Union approval. Kisqali will be used as a first-line treatment for a difficult-to-treat breast cancer. The company expects Kisqali to be a
